Optical See-through Head-mounted Display (OST-HMD)–assisted Needle Biopsy for Breast Tumor: A Technical Innovation

8Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background/Aim: Augmented reality (AR) is a new technology that provides new awareness by using a computer to extend the real environment perceived by humans. Optical see-through head-mounted displays (OST-HMD) are worn on the head and can faithfully generate an AR image by wearing the device on the head as a spectacle-type device. We developed an ultrasound-guided needle biopsy technique using OST-HMD for breast tumors. Patients and Methods: Moverio BT-35E (Seiko Epson Corp, Nagano, Japan) was used as the OST-HMD device. This technique involves performing needle biopsy under direct vision via the gap at the bottom of the display while the ultrasound images are projected on the display of the OST-HMD worn on the head. Results: With this technique, needle biopsy can be executed smoothly with no posture restrictions. A flip shade affixed to the OST-HMD has 2% transmittance, which enables clearer projection of the images. Conclusion: This article outlines the ultrasound-guided needle biopsy using OST-HMD. We established a safe and accurate biopsy technique with technological innovations using AR.

Cite

CITATION STYLE

APA

Kashiwagi, S., Asano, Y., Goto, W., Morisaki, T., Shibutani, M., Tanaka, H., … Ohira, M. (2022). Optical See-through Head-mounted Display (OST-HMD)–assisted Needle Biopsy for Breast Tumor: A Technical Innovation. In Vivo, 36(2), 848–852. https://doi.org/10.21873/INVIVO.12772

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free